Digital PNG artwork · delivered by email | Secure checkout · no physical shipping

GHK-Cu, BPC-157, TB-500 'Glow' Stack: What Dosing Guidance Really Exists

A TikTok clip promises dosing resources for the 'Glow' or 'Wolverine' stack of GHK-Cu, BPC-157, and TB-500. We examine the evidence behind each peptide and the lack of standardized dosing protocols.

GHK-Cu, BPC-157, TB-500 'Glow' Stack: What Dosing Guidance Really Exists

A recent TikTok clip from Cristina with no H offers "guidance on resources for dosing" the so-called Glow or Wolverine peptide stack, which combines GHK-Cu, BPC-157, and TB-500. The video implies that reliable dosing information exists and that viewers can find it through certain resources. But what does the research actually say about these three peptides, and is there any consensus on how to dose them together?

What the Clip Claims

The clip positions the Glow stack as a well-established combination, suggesting that dosing guidance is readily available. It references the popular nickname "Wolverine stack," which implies a synergistic effect for recovery and skin health. However, the video does not specify the exact resources or provide any dosing numbers, leaving viewers to search on their own.

The Research Neighborhood

Each peptide in the stack has a distinct research profile. GHK-Cu is a copper peptide studied for wound healing, collagen synthesis, and antioxidant activity. BPC-157, a synthetic pentadecapeptide derived from a stomach protein, has been investigated in animal models for tendon, ligament, and gastrointestinal healing. TB-500 (Thymosin Beta-4) is studied for its role in cell migration, angiogenesis, and tissue repair. While these mechanisms overlap, research on their combined use is virtually nonexistent.

Limits and Missing Context

A 15-second clip cannot convey the complexity of peptide research. For instance, GHK-Cu's effects are dose-dependent and may vary with the carrier. BPC-157 is often studied in animal models, and its stability in solution is a concern. TB-500's half-life and dosing frequency are still under investigation. The clip omits that no clinical trials have established safe or effective doses for this combination in humans. It also fails to mention that research-use peptides are not approved for human consumption, and any dosing guidance is speculative.

Mapping to Catalog Compounds

For researchers exploring these peptides, the catalog includes GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4) individually, as well as a BPC-157 + TB-500 blend. There is also a "Glow" blend, which likely contains GHK-Cu and other peptides, but the exact composition is not specified here. Researchers should note that the "Glow" blend may not match the exact stack mentioned in the clip, and dosing should be based on individual peptide research, not pre-mixed assumptions.

Research-Use Caveat

All peptides listed are for research use only (RUO) and are not intended for human or animal use. No dosing guidance provided by any source should be interpreted as medical advice. Researchers must design their own protocols based on peer-reviewed literature and institutional guidelines.

Open the full video fact-check page (transcript, takeaways, embedded clip).

WhatsApp